Form 4 for VCEL Vericel Corp
Accepted 2024-01-16 00:00:00 ET · period of report 2024-01-12 · accession 0001140361-24-002336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-01-16 | 2024-01-12 | VCEL | ZERBE ROBERT L MD | Dir | S - Sale | $38.09 | -2,200 | 30.9K | -7% | -$83.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-12 | S | D | 2,200 | $38.09 | 30,895 | D | — | — | (F1) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. |